News

Two IRIC projects selected in the Cancer Research Society’s most recent annual competition

Published on October 3, 2022

The Cancer Research Society (CRS) has announced the recipients of 90 new research grants. With a total value of $10.8 million, these grants support the most promising cancer research projects in the country.

IRIC is proud to have two of its teams among the selected projects:

  • David Knapp, Director of the Cellular Engineering Research Unit, is awarded $60,000 per year for a two-year period for the project “Modelling the progression from clonal hematopoiesis to leukemia”.
  • Sylvie Mader, Director of the Molecular Targeting in Breast Cancer Treatment Research Unit, is awarded a grant of $60,000 per year for two years for the project “Roles of the transcription factor FOXA1 in breast tumorigenesis”.

Congratulations to both teams!